Search

everythinglearnresearchcommunity

for

Search:↓

The treatment is safe and shows promise for metastatic breast cancer.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

Anti-androgen drugs can help reduce OCD symptoms, but more large-scale trials are needed to confirm their effectiveness.

Cyclosporin extends hair growth in mice, but high-dose corticosteroids block this effect.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Dutasteride mesotherapy can cause hair loss in some people.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Certain Dibenzo derivatives may help treat prostate cancer.

Sorafenib can cause a unique skin reaction.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

Adequate steroid treatment needed to limit bone loss in PMR patients.

Deoxycorticosterone and its metabolites help prevent seizures by interacting with specific receptors.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.